51. Longitudinal changes in leukocyte telomere length and mortality in elderly Swedish men
- Author
-
Xiaotian Yuan, Dawei Xu, Mai-Lis Hellénius, Per Sjögren, Tommy Cederholm, and Magnus Kronström
- Subjects
0301 basic medicine ,Male ,Aging ,Time Factors ,cause-specific mortality ,Lower risk ,Risk Assessment ,03 medical and health sciences ,0302 clinical medicine ,Sex Factors ,Risk Factors ,Cause of Death ,Neoplasms ,telomere length ,cohort study ,Leukocytes ,Medicine ,Humans ,Cardiac and Cardiovascular Systems ,Longitudinal Studies ,Telomere Shortening ,Cardiovascular mortality ,Aged ,Cancer mortality ,Aged, 80 and over ,Sweden ,Kardiologi ,business.industry ,Hazard ratio ,Age Factors ,Cause specific mortality ,longitudinal changes ,Cell Biology ,Telomere ,mortality ,030104 developmental biology ,Increased risk ,Cardiovascular Diseases ,business ,030217 neurology & neurosurgery ,Cohort study ,Demography ,Research Paper - Abstract
Telomere length (TL) is considered an indicator of aging and age-related diseases, but longitudinal studies on TL changes and mortality are few. We therefore analyzed TL and longitudinal changes in TL in relation to all-cause, cardiovascular, and cancer mortality in 247 elderly Swedish men. TL was determined by the qPCR method at ages 71 and 81 and subsequent mortality cases were identified from the Swedish cause-of-death registry. Cox proportional hazard ratios were calculated during a mean follow-up of 7.4 years, during which 178 deaths occurred. Short telomeres at baseline was strongly associated with mortality risks, with a 40 to 70% increased risk of all-cause mortality, and a 2-fold increased risk of cancer mortality. Longitudinal changes in TL revealed shortening in 83% of individuals, whilst 10% extended their telomeres. TL attrition did not predict all-cause or cancer mortality, but we found a 60% decreased risk for cardiovascular mortality in those who shortened their telomeres. Our data show an increased risk of mortality in individuals with short baseline telomeres, but no relations to all-cause, and cancer mortality for changes in TL. Intriguingly, our data indicate lower risk of cardiovascular mortality with shortening of telomeres. The latter should be interpreted cautiously.
- Published
- 2018